-
Nasal bone in first-trimester screening for trisomy 21.
Cicero S, Avgidou K, Rembouskos G, Kagan KO, Nicolaides KH.
Am J Obstet Gynecol 2006;195:109-14. -
Fetal nuchal translucency scan and early prenatal diagnosis of chromosomal abnormalities by rapid aneuploidy screening: observational study.
Chitty LS, Kagan KO, Molina FS, Waters JJ, Nicolaides KH.
BMJ 2006;332:452-5. -
Aneuploidy screening in a coelomic sample from a missed abortion using sequential fluorescence in situ hybridization.
Chatzimeletiou K, Makrydimas G, Nicolaides KH.
Fertil Steril 2006;85:1059. -
Hypermethylated RASSF1A in Maternal Plasma: A Universal Fetal DNA Marker that Improves the Reliability of Noninvasive Prenatal Diagnosis.
Chan KC, Ding C, Gerovassili A, Yeung SW, Chiu RW, Leung TN, Lau TK, Chim SS, Chung GT, Nicolaides KH, Lo YM.
Clin Chem 2006;52:2211-8. -
Brachycephaly and frontal lobe hypoplasia in fetuses with trisomy 21 at 11 + 0 to 13 + 6 weeks.
Borenstein M, Dagklis T, Csapo B, Sotiriadis A, Nicolaides KH.
Ultrasound Obstet Gynecol 2006;28:870-5. -
Maternal cardiac function in fetal growth restriction.
Bamfo JE, Kametas NA, Turan O, Khaw A, Nicolaides KH.
BJOG 2006;113:784-91. -
The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues.
Wilting J, Papoutsi M, Christ B, Nicolaides KH, von Kaisenberg CS, Borges J, Stark GB, Alitalo K, Tomarev SI, Niemeyer C, Rossler J.
FASEB J 2002;16:1271-3. -
Cervical screening for preterm delivery.
Welsh A, Nicolaides K.
Curr Opin Obstet Gynecol 2002;14:195-202. -
Elective cerclage vs ultrasound-indicated cerclage in high-risk pregnancies.
To MS, Palaniappan V, Skentou C, Gibb D, Nicolaides KH.
Ultrasound Obstet Gynecol 2002;19:475-7. -
A first trimester trisomy 13/trisomy 18 risk algorithm combining fetal nuchal translucency thickness, maternal serum free beta-hCG and PAPP-A.
Spencer K, Nicolaides KH.
Prenat Diagn 2002;22:877-9. -
Congenital nephrotic syndrome presenting with increased nuchal translucency in the first trimester.
Souka AP, Skentou H, Geerts L, Bower S, Nicolaides KH.
Prenat Diagn 2002;22:93-5. -
Congenital lymphedema presenting with increased nuchal translucency at 13 weeks of gestation.
Souka AP, Krampl E, Geerts L, Nicolaides KH.
Prenat Diagn 2002;22:91-2. -
Hypophosphatasia associated with increased nuchal translucency: a report of two affected pregnancies.
Souka AP, Raymond FL, Mornet E, Geerts L, Nicolaides KH.
Ultrasound Obstet Gynecol 2002;20:294-5. -
Blackfan-Diamond anemia and dyserythropoietic anemia presenting with increased nuchal translucency at 12 weeks of gestation.
Souka AP, Bower S, Geerts L, Huggon I, Nicolaides KH.
Ultrasound Obstet Gynecol 2002;20:197-9. -
Prenatal ultrasonographic diagnosis of nasal bone abnormalities in three fetuses with Down syndrome.
Sonek JD, Nicolaides KH.
Am J Obstet Gynecol 2002;186:139-41. -
Impaired vascular reactivity in pregnant women with insulin-dependent diabetes mellitus.
Savvidou MD, Geerts L, Nicolaides KH.
Am J Obstet Gynecol 2002;186:84-8. -
Levels of C-reactive protein in pregnant women who subsequently develop pre-eclampsia.
Savvidou MD, Lees CC, Parra M, Hingorani AD, Nicolaides KH.
BJOG 2002;109:297-301. -
Second-trimester uterine artery Doppler screening in unselected populations: a review.
Papageorghiou AT, Yu CK, Cicero S, Bower S, Nicolaides KH.
J Matern Fetal Neonatal Med 2002;12:78-88. -
Trichorionic triplet pregnancies at 10-14 weeks: outcome after embryo reduction compared to expectant management.
Papageorghiou AT, Liao AW, Skentou C, Sebire NJ, Nicolaides KH.
J Matern Fetal Neonatal Med 2002;11:307-12. -
Increased fetal nuchal translucency at 11-14 weeks.
Nicolaides KH, Heath V, Cicero S.
Prenat Diagn 2002;22:308-15.